Pharming Group - Stock Price History | PHAR

Historical daily share price chart and data for Pharming Group since 2021 adjusted for splits. The latest closing stock price for Pharming Group as of September 24, 2021 is 9.90.
  • The all-time high Pharming Group stock closing price was 16.70 on December 23, 2020.
  • The Pharming Group 52-week high stock price is 21.99, which is 122.1% above the current share price.
  • The Pharming Group 52-week low stock price is 9.43, which is 4.7% below the current share price.
  • The average Pharming Group stock price for the last 52 weeks is 12.46.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pharming Group Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 15.2892 16.7000 16.7000 14.5000 15.1950 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.640B $0.212B
Pharming Group N.V. is a commercial stage biopharmaceutical company. It engages in developing protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The company's product portfolio includes C1INH. Pharming Group N.V. is based in Leiden, The Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71